Samsung Biologics Wins 350.8 Billion Won CMO Deal With European Drugmaker
A view of Samsung Biologics’ Plant 4. Photo courtesy of Samsung Biologics Samsung Biologics (207940) has signed a…
#EuropeSays #Korea #KR #SamsungBiologics #biopharmaceuticalmanufacturing #CDMOmarket #CMOcontract #contractmanufacturing #productioncapacity #Samsung #SongdoBioCampus
https://www.europesays.com/korea/149825/